Inobe, J <br/><br/>
IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis.  [electronic resource] 

 -  European journal of immunology  Sep 1998 
 - 2780-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0014-2980 
<br/><br/><label>Standard No.: </label>10.1002/(SICI)1521-4141(199809)28:09<2780::AID-IMMU2780>3.0.CO;2-J  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Autoimmunity--immunology<br/>Cells, Cultured<br/>Encephalomyelitis, Autoimmune, Experimental--immunology<br/>Female<br/>Immune Tolerance--drug effects<br/>Interleukin-4--immunology<br/>Mice<br/>Mice, Transgenic<br/>Myelin Basic Protein--administration & dosage<br/>Spleen--immunology<br/>T-Lymphocytes, Helper-Inducer--immunology<br/>Transforming Growth Factor beta--immunology